Cannabis stocks mostly higher as sector braces for FDA hearing on rules for CBD

Cannabis stocks were mostly higher Tuesday, as investors braced for a Thursday hearing by the U.S. Food and Drug Administration on how to regulate cannabis and its popular ingredient, CBD.